Pure Financial Advisors LLC Acquires New Holdings in Colgate-Palmolive Company $CL

Pure Financial Advisors LLC bought a new position in shares of Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 13,495 shares of the company’s stock, valued at approximately $1,237,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Flputnam Investment Management Co. boosted its holdings in shares of Colgate-Palmolive by 7.4% during the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock worth $15,881,000 after acquiring an additional 13,804 shares during the period. SEB Asset Management AB bought a new position in shares of Colgate-Palmolive during the first quarter worth approximately $91,149,000. Brandywine Financial Group lifted its holdings in Colgate-Palmolive by 35,612.3% during the 1st quarter. Brandywine Financial Group now owns 72,853 shares of the company’s stock worth $6,209,000 after purchasing an additional 72,649 shares during the last quarter. Conning Inc. boosted its stake in Colgate-Palmolive by 10.2% in the 4th quarter. Conning Inc. now owns 426,753 shares of the company’s stock valued at $33,722,000 after purchasing an additional 39,655 shares during the period. Finally, First Eagle Investment Management LLC boosted its stake in Colgate-Palmolive by 0.4% in the 4th quarter. First Eagle Investment Management LLC now owns 7,918,979 shares of the company’s stock valued at $625,758,000 after purchasing an additional 29,876 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $92.12 on Thursday. The stock has a 50-day moving average price of $91.98 and a two-hundred day moving average price of $90.08. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a market capitalization of $73.44 billion, a PE ratio of 36.56, a P/E/G ratio of 4.27 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same period in the previous year, the firm posted $0.92 EPS. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, July 20th were paid a $0.53 dividend. The ex-dividend date of this dividend was Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s payout ratio is 84.13%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CL. Weiss Ratings reissued a “hold (c+)” rating on shares of Colgate-Palmolive in a report on Friday, July 31st. TD Cowen raised their price target on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, August 3rd. Citigroup boosted their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 8th. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $99.00.

Insiders Place Their Bets

In other news, CEO Noel R. Wallace sold 161,021 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This trade represents a 30.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the sale, the director owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 175,191 shares of company stock worth $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.